PDF(Sci-hub)
Abstract：
Patients have historically travelled from across the world to the United States for medical care that is not accessible locally or not available at the same perceived quality. The COVID-19 pandemic has nearly frozen the cross-border buying and selling of healthcare services, referred to as medical tourism. Future medical travel to the United States may also be deterred by the combination of an initially uncoordinated public health response to the pandemic, an overall troubled atmosphere arising from widely publicized racial tensions and pandemic-related disruptions among medical services providers. American hospitals have shifted attention to domestic healthcare needs and risk mitigation to reduce and recover from financial losses. While both reforms to the US healthcare system under the Biden Presidency and expansion to the Affordable Care Act will influence inbound and outbound medical tourism for the country, new international competitors are also likely to have impacts on the medical tourism markets. In response to the COVID-19 pandemic, US-based providers are forging new and innovative collaborations for delivering care to patients abroad that promise more efficient and higher quality of care which do not necessitate travel.
摘要：
历史上，患者从世界各地前往美国寻求当地无法获得或无法以相同的感知质量获得的医疗服务。新冠肺炎疫情几乎冻结了医疗服务的跨境买卖，被称为医疗旅游。未来前往美国的医疗旅行也可能因最初不协调的公共卫生应对大流行而受到阻碍，由于广泛宣传的种族紧张局势和医疗服务提供者之间与大流行有关的干扰而产生的整体混乱气氛。美国医院已经将注意力转移到国内医疗保健需求和风险缓解上，以减少和恢复财务损失。虽然在拜登担任总统期间对美国医疗体系进行的两项改革以及对《平价医疗法案》的扩展都将影响该国的入境和出境医疗旅游，新的国际竞争对手也可能对医疗旅游市场产生影响。为了应对COVID-19大流行，美国的医疗服务提供者正在建立新的和创新的合作，为国外患者提供护理，承诺更有效和更高质量的护理，而不需要旅行。
